Purpose: Two pathways, hyperdiploid and nonhyperdiploid, are proposed for progression to plasma cell neoplasia. Implication of monosomy 13 (D13) is unclear in monoclonal gammopathy of undetermined significance (MGUS), and data on DNA content of plasma cells [DNA index (DI)] are rare. Experimental Design: We ascertained DI in 169 multiple myeloma (MM) and 96 MGUS patients. Interphase fluorescence in situ hybridization (FISH) coupled to cytoplasmic staining of specific Ig (cIg-FISH) was done to look for trisomies and to ascertain D13. Results: Hyperdiploidy and hypodiploidy were found in 54% and 11.5% of MGUS patients and in 59.5% and 25% of MM patients, respectively. In MGUS patients tested using probes for odd chromosomes, cIg-FISH showed association between trisomies for chromosomes 3, 7, 9, 11, or 15 and hyperdiploidy. D13 was found in 45.3% and 24.6% of MM and MGUS patients, respectively. Most D13 cases observed in MGUS were found within hyperdiploid clones, 38% versus 11% in hypodiploid cases, in sharp contrast with the occurrence of D13 in MM patients, 31.9% and 76.3%, respectively. That peculiar distribution of D13 according to DI persisted with other thresholds used to ascertain hyperdiploidy, such as DI z 1.05. A strong relationship between IgA peak and hypodiploidy (P = 0.007) was only observed in MM, whereas E light chain was significantly associated with hypodiploidy in MGUS (P = 0.001) and MM (P = 0.05). Hyperdiploidy shows similar pattern in MGUS and MM. Conclusion:This fits well a hyperdiploid pathway leading to MM after a preceding MGUS stage. Yet-to-be-determined secondary event(s) needs to occur for the transition to MM, unrelated to changes in chromosome number or to loss of chromosome 13. In contrast, the ''nonhyperdiploid'' pathway needs to be clarified further because hypodiploidy is less common in MGUS than in MM and D13 is rare in hypodiploid MGUS patients compared with hypodiploid MM patients.Karyotypes from multiple myeloma (MM) patients are complex but may be categorized either as hyperdiploid, displaying gain of odd chromosomes and some structural changes, or as hypodiploid or pseudodiploid, displaying loss of even chromosomes and frequent structural changes, including IgH rearrangements (1, 2). Interphase fluorescence in situ hybridization (FISH) studies done on large series of MM patients have shown that chromosome changes are observed in almost all MM patients (3) and that monosomy 13 (D13), hypodiploidy, and some IgH translocations are related to adverse prognosis in MM (1, 2, 4 -11).Monoclonal gammopathy of undetermined significance (MGUS) is an indolent condition that can progress to malignant MM at a rate of 0.6% to 3% yearly (12, 13). With some exceptions (14, 15), conventional cytogenetic study is unsuccessful in MGUS, and most information about cytogenetic status has been drawn from interphase FISH studies done on bone marrow plasma cells (BMPC). Numerical chromosome changes are observed in up to 60% (16 -19) and IgH translocations in up to 48% of patients tested (...